Effects of agomelatine on behaviour, circadian expression of period 1 and period 2 clock genes and neuroplastic markers in the predator scent stress rat model of PTSD
- PMID: 30230406
- DOI: 10.1080/15622975.2018.1523560
Effects of agomelatine on behaviour, circadian expression of period 1 and period 2 clock genes and neuroplastic markers in the predator scent stress rat model of PTSD
Abstract
Objectives: The therapeutic value of the antidepressant agomelatine in the aftermath of traumatic experience and early post-reminder has been questioned. Herein, agomelatine, its vehicle or melatonin agonist were administered either acutely 1 h post-stressor or repeatedly (7 days) after early post-reminder in a post-traumatic stress rat model (PSS) using the scent of predator urine.Methods: Behavioural responses, and brain molecular and morphological changes were evaluated after each treatment procedure in PSS-exposed and unexposed rats.Results: When administered immediately after PSS, agomelatine induced a significant reduction of anxiety-like behaviour as assessed in the elevated-plus-maze and acoustic startle response at 8 days post-administration. Concomitantly, agomelatine significantly decreased Per1/Per2 expression in the CA1/CA3 areas, suprachiasmatic nucleus and basolateral amygdala, thereby partially restoring genes expression overregulated by PSS. Agomelatine further significantly increased cell growth and facilitated dendritic growth and arbour in dentate gyrus (DG) granule and apical CA1 cells and upregulated brain-derived neurotrophic factor protein in the DG and cortex III versus vehicle. When administered early post-reminder over 7 days before testing, agomelatine was ineffective on behavioural responses pattern, molecular and morphological changes induced by PSS.Conclusions: These findings suggest that agomelatine may be a potential agent in the acute aftermath of traumatic stress exposure.
Keywords: PTSD animal model; agomelatine; early intervention; melatonin; secondary prevention.
Similar articles
-
The long-term abnormalities in circadian expression of Period 1 and Period 2 genes in response to stress is normalized by agomelatine administered immediately after exposure.Eur Neuropsychopharmacol. 2012 Mar;22(3):205-21. doi: 10.1016/j.euroneuro.2011.07.012. Epub 2011 Sep 16. Eur Neuropsychopharmacol. 2012. PMID: 21925847
-
The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder.Neuropsychopharmacology. 2012 Jan;37(2):350-63. doi: 10.1038/npp.2011.230. Epub 2011 Oct 5. Neuropsychopharmacology. 2012. PMID: 21976046 Free PMC article.
-
Agomelatine-induced modulation of brain-derived neurotrophic factor (BDNF) in the rat hippocampus.Life Sci. 2018 Oct 1;210:177-184. doi: 10.1016/j.lfs.2018.09.003. Epub 2018 Sep 4. Life Sci. 2018. PMID: 30193943
-
[Development of a new antidepressant : agomelatine].Med Sci (Paris). 2005 Oct;21(10):888-93. doi: 10.1051/medsci/20052110888. Med Sci (Paris). 2005. PMID: 16197911 Review. French.
-
Agomelatine: a preliminary review of a new antidepressant.CNS Drugs. 2006;20(12):981-92. doi: 10.2165/00023210-200620120-00003. CNS Drugs. 2006. PMID: 17140278 Review.
Cited by
-
Melatonin for premenstrual syndrome: A potential remedy but not ready.Front Endocrinol (Lausanne). 2023 Jan 9;13:1084249. doi: 10.3389/fendo.2022.1084249. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36699021 Free PMC article. Review.
-
Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action.Ther Adv Psychopharmacol. 2022 Jun 30;12:20451253221105128. doi: 10.1177/20451253221105128. eCollection 2022. Ther Adv Psychopharmacol. 2022. PMID: 35795687 Free PMC article. Review.
-
Increased 5-HT2C receptor editing predisposes to PTSD-like behaviors and alters BDNF and cytokines signaling.Transl Psychiatry. 2019 Feb 21;9(1):100. doi: 10.1038/s41398-019-0431-8. Transl Psychiatry. 2019. PMID: 30792491 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous